Maintenance is scheduled between 9pm - 12 am AEST, Friday 1 May 2026 and the site may be unavailable or slow during this time.
This item is authorised by the following title:
Transitional: see section 60 of this instrument for transitional provisions.
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2024 (No. 2) (PB 19 of 2024 | F2024L00243)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2024 (No. 1) (PB 6 of 2024 | F2024L00122)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2023 (No. 12) (PB 133 of 2023 | F2023L01752)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2023 (No. 11) (PB 117 of 2023 | F2023L01586)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2023 (No. 10) (PB 108 of 2023 | F2023L01449)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2023 (No. 9) (PB 95 of 2023 | F2023L01330)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2023 (No. 8) (PB 85 of 2023 | F2023L01153)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2023 (No. 7) (PB 72 of 2023 | F2023L01042)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2023 (No. 6) (PB 59 of 2023 | F2023L00931)
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2023 (No. 5) (PB 47 of 2023 | F2023L00650)
National Health Legislation Amendment (Conditions of Approval for Approved Pharmacists) Instrument 2023 (PB 17 of 2023 | F2023L00511)
View Explanatory Statement/s
Transitional: see section 60 of this instrument for transitional provisions.